↓ Read PDF
01 · ABSTRACT

Abstract

Elevated neutrophil to lymphocyte ratio (NLR) upon ICU admission has been reported to be associated with disease progression, severity, or mortality in critically ill patients. However, the overtime trajectories of NLR after admission and their association with other markers of intensive care units patients’ immuno-inflammatory status have not be evaluated so far. In a cohort of 353 critically ill patients (sepsis, trauma, major surgery), we evaluated the association between NLR trajectories and patients’ deterioration (mortality or occurrence of nosocomial infection) both by a conventional analysis at each time-point and through K-means clustering analysis.  Additionally, these trajectories were delineated alongside established markers of hyper-inflammation (e.g., IL-6) or immunosuppression (including HLA-DR expression on monocytes, proportion of immature neutrophils, and plasma IL-10 levels). The results showed that persistently elevated NLR values were associated with an increased risk of patient deterioration, as demonstrated in a multivariate analysis that included usual clinical confounders. Patients belonging to the persistently elevated NLR endotype simultaneously exhibited heightened inflammation and pronounced immunosuppression. In conclusion, by providing integrated information on both hyper-inflammation and immunosuppression, NLR measurement holds significant promise for monitoring the immune status of ICU patients. This straightforward and standardized marker could serve to assess immune organ failure in ICU and assist in guiding potential immunomodulation strategies.

↓ Read PDF
02 · PUBLICATION RECORD

Article details

JournalMedical Research Archives
IssueVol 13 No 2 (2025): Vol.13 issue 2 February 2025
SectionResearch Articles
Published27 February 2025
DOI10.18103/mra.v13i2.6315
ISSN2375-1924
03 · RIGHTS & REUSE

Rights & reuse

This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.

Authors & affiliations

AR

Alejandra Restrepo

Hospices Civils de Lyon, Immunology Laboratory, Hôpital E. Herriot, Lyon France

MR

Muzhda Haem Rahimi

Hospices Civils de Lyon, Immunology Laboratory, Hôpital E. Herriot, Lyon France; Université de Lyon, EA 7426 “Pathophysiology of Injury-Induced Immunosuppression”, Université Claude Bernard Lyon_1, Lyon, France

MB

Maxime Bodinier

Université de Lyon, EA 7426 “Pathophysiology of Injury-Induced Immunosuppression”, Université Claude Bernard Lyon_1, Lyon, France; Open Innovation & Partnerships, bioMérieux S.A., Marcy l'Etoile, France

MG

Morgane Gossez

Hospices Civils de Lyon, Immunology Laboratory, Hôpital E. Herriot, Lyon France; CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm U1111, Université Claude Bernard-Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France

AL

Anne-Claire Lukaszewicz

Université de Lyon, EA 7426 “Pathophysiology of Injury-Induced Immunosuppression”, Université Claude Bernard Lyon_1, Lyon, France; Hospices Civils de Lyon, Anesthesiology and Critical Care Medicine department, Hôpital E. Herriot, Lyon, France

TR

Thomas Rimmelé

Université de Lyon, EA 7426 “Pathophysiology of Injury-Induced Immunosuppression”, Université Claude Bernard Lyon_1, Lyon, France; Hospices Civils de Lyon, Anesthesiology and Critical Care Medicine department, Hôpital E. Herriot, Lyon, France  

FV

Fabienne Venet

Hospices Civils de Lyon, Immunology Laboratory, Hôpital E. Herriot, Lyon France; Université Claude Bernard-Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France

GM

Guillaume Monneret

Hospices Civils de Lyon, Immunology Laboratory, Hôpital E. Herriot, Lyon France; Université de Lyon, EA 7426 “Pathophysiology of Injury-Induced Immunosuppression”, Université Claude Bernard Lyon_1, Lyon, France

Medical Research Archives

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Start your submission  ↗